Sivik Global Healthcare LLC / BIIB
Sivik Global Healthcare LLC’s Biogen Inc Position
Does Sivik Global Healthcare LLC own Biogen Inc (BIIB)? Yes — 15.0K shares worth $3M (+2.09% of its 13F portfolio) as of Q1 2026, down from 20.0K shares the prior filed quarter.
Position Value
$3M
Q1 2026
Shares
15.0K
% of Portfolio
+2.09%
Quarters Held
17
currently held
Position History BIIB
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 15.0K | $3M | +2.09% |
| Q4 2025 | 20.0K | $4M | +1.02% |
| Q2 2024 | 30.0K | $7M | +2.50% |
| Q1 2024 | 10.0K | $2M | +0.51% |
| Q4 2023 | 25.0K | $6M | +2.70% |
| Q2 2023 | 10.0K | $3M | +0.67% |
| Q1 2023 | 10.0K | $3M | +1.20% |
| Q4 2022 | 10.0K | $3M | +1.30% |
| Q3 2022 | 10.0K | $3M | +1.48% |
| Q2 2021 | 20.0K | $7M | +1.35% |
| Q1 2021 | 12.5K | $3M | +1.28% |
| Q3 2020 | 12.0K | $3M | +1.46% |
| Q2 2020 | 15.0K | $4M | +1.33% |
| Q1 2020 | 20.0K | $6M | +2.50% |
| Q4 2019 | 20.0K | $6M | +2.20% |
| Q1 2019 | 15.0K | $4M | +1.31% |
| Q4 2018 | 20.0K | $6M | +3.24% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of BIIB.